Literature DB >> 34941261

Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.

Antonieta L Salguero1,2,3, Maggie Chen1,2,4, Aaron T Balana5, Nam Chu6, Hanjie Jiang1,2,3, Brad A Palanski1,2, Hwan Bae1,2, Katharine M Wright7, Sara Nathan7, Heng Zhu3,8, Sandra B Gabelli7,9,10, Matthew R Pratt11, Philip A Cole1,2,3.   

Abstract

Akt is a Ser/Thr protein kinase that regulates cell growth and metabolism and is considered a therapeutic target for cancer. Regulation of Akt by membrane recruitment and post-translational modifications (PTMs) has been extensively studied. The most well-established mechanism for cellular Akt activation involves phosphorylation on its activation loop on Thr308 by PDK1 and on its C-terminal tail on Ser473 by mTORC2. In addition, dual phosphorylation on Ser477 and Thr479 has been shown to activate Akt. Other C-terminal tail PTMs have been identified, but their functional impacts have not been well-characterized. Here, we investigate the regulatory effects of phosphorylation of Tyr474 and O-GlcNAcylation of Ser473 on Akt. We use expressed protein ligation as a tool to produce semisynthetic Akt proteins containing phosphoTyr474 and O-GlcNAcSer473 to dissect the enzymatic functions of these PTMs. We find that O-GlcNAcylation at Ser473 and phosphorylation at Tyr474 can also partially increase Akt's kinase activity toward both peptide and protein substrates. Additionally, we performed kinase assays employing human protein microarrays to investigate global substrate specificity of Akt, comparing phosphorylated versus O-GlcNAcylated Ser473 forms. We observed a high similarity in the protein substrates phosphorylated by phosphoSer473 Akt and O-GlcNAcSer473 Akt. Two Akt substrates identified using microarrays, PPM1H, a protein phosphatase, and NEDD4L, an E3 ubiquitin ligase, were validated in solution-phase assays and cell transfection experiments.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34941261      PMCID: PMC8864695          DOI: 10.1021/acschembio.1c00632

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  49 in total

Review 1.  Akt/PKB: one kinase, many modifications.

Authors:  Guillermo Risso; Matías Blaustein; Berta Pozzi; Pablo Mammi; Anabella Srebrow
Journal:  Biochem J       Date:  2015-06-01       Impact factor: 3.857

2.  Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.

Authors:  Pengda Liu; Michael Begley; Wojciech Michowski; Hiroyuki Inuzuka; Miriam Ginzberg; Daming Gao; Peiling Tsou; Wenjian Gan; Antonella Papa; Byeong Mo Kim; Lixin Wan; Amrik Singh; Bo Zhai; Min Yuan; Zhiwei Wang; Steven P Gygi; Tae Ho Lee; Kun-Ping Lu; Alex Toker; Pier Paolo Pandolfi; John M Asara; Marc W Kirschner; Piotr Sicinski; Lewis Cantley; Wenyi Wei
Journal:  Nature       Date:  2014-03-09       Impact factor: 49.962

3.  α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.

Authors:  Paul M Levine; Ana Galesic; Aaron T Balana; Anne-Laure Mahul-Mellier; Mariana X Navarro; Cesar A De Leon; Hilal A Lashuel; Matthew R Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-16       Impact factor: 11.205

4.  PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

Authors:  John Brognard; Emma Sierecki; Tianyan Gao; Alexandra C Newton
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.

Authors:  Jack M Heath; Yong Sun; Kaiyu Yuan; Wayne E Bradley; Silvio Litovsky; Louis J Dell'Italia; John C Chatham; Hui Wu; Yabing Chen
Journal:  Circ Res       Date:  2014-02-13       Impact factor: 17.367

7.  The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C.

Authors:  Valeria Facchinetti; Weiming Ouyang; Hua Wei; Nelyn Soto; Adam Lazorchak; Christine Gould; Carolyn Lowry; Alexandra C Newton; Yuxin Mao; Robert Q Miao; William C Sessa; Jun Qin; Pumin Zhang; Bing Su; Estela Jacinto
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

8.  Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo.

Authors:  Véronique Calleja; Damien Alcor; Michel Laguerre; Jongsun Park; Borivoj Vojnovic; Brian A Hemmings; Julian Downward; Peter J Parker; Banafshé Larijani
Journal:  PLoS Biol       Date:  2007-04       Impact factor: 8.029

9.  Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis.

Authors:  David Bolduc; Meghdad Rahdar; Becky Tu-Sekine; Sindhu Carmen Sivakumaren; Daniel Raben; L Mario Amzel; Peter Devreotes; Sandra B Gabelli; Philip Cole
Journal:  Elife       Date:  2013-07-09       Impact factor: 8.140

10.  The structural determinants of PH domain-mediated regulation of Akt revealed by segmental labeling.

Authors:  Nam Chu; Thibault Viennet; Hwan Bae; Antonieta Salguero; Andras Boeszoermenyi; Haribabu Arthanari; Philip A Cole
Journal:  Elife       Date:  2020-08-03       Impact factor: 8.140

View more
  1 in total

1.  PH domain-mediated autoinhibition and oncogenic activation of Akt.

Authors:  Hwan Bae; Thibault Viennet; Eunyoung Park; Nam Chu; Antonieta Salguero; Michael J Eck; Haribabu Arthanari; Philip A Cole
Journal:  Elife       Date:  2022-08-15       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.